Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

HedgeMark Institutional Consultants announces Hiroshi Harada as MD and Head of Hedge Fund Research

Monday, April 11, 2011
Opalesque Industry Update - HedgeMark Institutional Consultants, LLC (HMIC), a wholly owned subsidiary of HedgeMark International, LLC, announced that Hiroshi Harada has joined the firm as Managing Director and Head of Hedge Fund Research. In his new role, Mr. Harada will head the team responsible for the sourcing, due diligence, and monitoring of funds on the company’s managed accounts platform.

Mr. Harada is well established in the global hedge fund industry and was Head of Hedge Fund Research for the funds-of-hedge-funds division of Nomura Fund Research and Technologies America, Inc. (NFR&TA or Nomura), where he managed two departments and a ten-person analyst team. He joined Nomura in 2004 and was responsible for fund selection, fund due diligence and the development and management of investment products for Nomura’s multi-billion dollar hedge fund and managed accounts platform. In this role, Mr. Harada chaired Nomura’s Funds Rating and Investment Committees and was responsible for the daily investment guideline monitoring of all platform managers. He also managed the research and analyst teams overseeing Nomura’s Fund of Hedge Fund business and was responsible for product development for the Bank’s distribution system based in Tokyo. The addition of Mr. Harada adds further depth to one of the industry’s strongest hedge fund managed account management teams. “Hiroshi brings tremendous experience in global manager sourcing and due diligence,” said Kenneth S. Phillips, the company’s founder and chief executive officer. “His experience and leadership skills reflect our commitment to building the industry’s premier institutional hedge fund platform.”

Prior to joining NFR&TA, Mr. Harada was a hedge fund analyst for ACAM Advisors LLC (ACAM), a wholly owned subsidiary of ITOCHU Corporation, one of the largest global conglomerates. From 1997 to 2002, he was a Manager with Dai-ichi Life International (Dai-ichi) New York, N.Y. with responsibilities for its reinsurance business in North America.

Mr. Harada holds a BA in Economics and History (cum laude) from Midwestern State University, Texas, and was awarded an MBA from New York University Leonard N. Stern School of Business in 2003.

(press release)

Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for